Physician

Ghazwan Atto, M.D.

According to 2025 Medicare claims, Ghazwan Atto, M.D. (NPI: 1578553301) practices internal medicine in the Detroit-Dearborn-Livonia, MI market, with the plurality of this provider's patient population coming from Wayne, MI. This provider's primary affiliated billing organization is GHAZWAN ATTO MD PC (NPI: 1669554903; TIN: 383577843) and primary practice location at 48192-4135. Atto is affiliated with the Aledade 93 National MSSP Enhanced (ACO ID: A5206), participating under the MSSP model.

Atto's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,193 traditional Medicare patients, billed 12,311 HCPCS/CPT codes, and received $1,821,690 in Medicare payments. The top billing code was G0439 (Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit). Part D data shows 23,990 prescription claims across 1,567 beneficiaries totaling $4,775,710 in drug costs, led by Korlym (Mifepristone). DME data shows 867 claims. Open Payments data shows 182 records totaling $2,674. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $1,321,310 to $1,821,690. Similarly, Part D prescription costs have risen steadily, from $2,214,255 to $4,775,710. In contrast, DME billing represents a smaller volume and moved from a lower plateau to a higher plateau, from $59,533 to $105,958.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,321	27,371	$1,321,310
2016	1,184	21,663	$978,102
2017	1,317	19,986	$980,845
2018	1,185	20,509	$851,825
2019	1,232	24,858	$911,899
2020	1,536	19,087	$1,071,080
2021	2,201	23,693	$1,379,621
2022	1,738	25,308	$1,793,990
2023	1,401	18,916	$1,025,185
2024	1,193	12,311	$1,821,690

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	1,135	24,790	$2,214,255
2016	1,267	29,348	$2,623,664
2017	1,372	34,790	$3,244,211
2018	1,447	32,161	$3,502,450
2019	1,519	28,915	$3,200,333
2020	1,726	29,386	$3,441,077
2021	1,720	29,020	$3,714,696
2022	1,793	27,751	$4,265,976
2023	1,658	26,788	$4,779,458
2024	1,567	23,990	$4,775,710

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	620	2,152	$89,782
2016	495	1,886	$89,753
2017	454	1,437	$48,055
2018	400	1,427	$55,355
2019	440	1,730	$91,338
2020	419	1,700	$98,576
2021	347	1,454	$80,674
2022	294	1,226	$86,198
2023	165	1,051	$91,510
2024	129	867	$89,422

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	310	310	$129
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	582	1,468	$92
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	448	874	$55
G0444	Annual depression screening, 5 to 15 minutes	255	255	$19
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	268	421	$13

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Korlym	Mifepristone	12	360	$484,079
Jardiance	Empagliflozin	386	22,490	$423,230
Eliquis	Apixaban	353	19,922	$371,834
Ozempic	Semaglutide	276	10,626	$315,865
Mounjaro	Tirzepatide	205	8,264	$296,425

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	22	98	$47,071
J7677	Revefenacin inhalation solution, fda-approved final product, non-compounded, administered through dme, 1 microgram	N	N/R	14	$10,669
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	18	108	$9,692
A4238	Supply allowance for adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	N/R	12	$4,259
J7606	Formoterol fumarate, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 20 micrograms	N	N/R	14	$2,015

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	182	$2,674	Novo Nordisk Inc
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Ghazwan Atto, M.D.?

Tedicare shows public-source Medicare data for Ghazwan Atto, M.D. (NPI 1578553301), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ghazwan Atto, M.D. have ACO affiliation data?

Ghazwan Atto, M.D. is shown with ACO affiliation data for Aledade 93 National MSSP Enhanced (MSSP, ACO ID A5206).

What billing organization is linked to Ghazwan Atto, M.D.?

Ghazwan Atto, M.D. is linked to GHAZWAN ATTO MD PC (billing NPI 1669554903) in the available physician profile data.

Does Ghazwan Atto, M.D. have Open Payments data?

Ghazwan Atto, M.D. has 182 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.